Breaking News, Promotions & Moves

Frontage Expands Business in Canada with New Leadership

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will spearhead growth as he continues to serve as Chief Scientific & Strategy Officer.

By: Rachel Klemovitch

Assistant Editor

Frontage Holdings Corporation has appointed Dr. Abdul Mutlib as the President of Frontage Laboratories, Canada. Mutlib will spearhead Frontage’s growth in the Canadian market and continue to serve as the Chief Scientific & Strategy Officer for Frontage Laboratories. 

This appointment reflects Frontage’s commitment to enhancing and expanding its services as a leading global pharmaceutical CRO.

Mutlib brings over 35 years of R&D experience in large pharmaceutical and CRO and will play a key role in establishing Frontage as a key partner and service provider to the rapidly growing biotech industry across Canada. 

Mutlib will have oversight of the Canadian operations based in Toronto and Vancouver. He will report to Co-Chief Executive Officer Dr. Wentao Zhang.

Dr. Zhang commented, “Abdul’s leadership and experience has been vital to Frontage’s growth over the last several years. His vision and strong leadership qualities will drive our success and expansion in Canada.”

“I’m excited to collaborate with Canadian authorities and establish Frontage as a leading provider of comprehensive, high-quality R&D services, supporting Canada’s vision to become a dynamic hub for biotechnology and pharmaceutical innovation,” said Mutlib.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters